References
- Jackman PG, Iakovidis D, Nero TL, Anavekar NS, Rezmann-Vitti LA, Louis SNS, Mori M, Drummer OH Louis WJ. Synthesis. β-adrenoreceptor pharmacology and toxicology of S-(-)-I-(4-(2-ethoxy)phenoxy)-2-hydroxy-3-(2-(3,4- dimethoxyphenyl)ethylamino)-propane hydrochloride, a short acting β1-specific antagonist. Eur J Med Chem 2002, 37:731-741.
- Bodor N, Buchwald P. Soft drug design: General principles and recent applications. Med Res 2000, 20:58-101.
- Kečkéšová S, Sedlárová E. Review of the ultra-short acting beta-adrenergic blockers. (in Slovak) Farm Obzor 2010, 79:3-13.
- Mokrý P, Macháčková Z, Pavlica J, Csöllei J. Synthesis and physicochemical properties of novel arylkarbonyloxyaminopropanol derivatives, Proceedings of 40th Drug Synthesis and Analysis Conference, Brno 2011, Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences Brno, ISBN 978 - 80 - 7305 - 596-6.
- Mokrý P, Zemanová M, Csöllei J, Račanská E, Tumová I. Synthesis and pharmacological evaluation of novel potential ultra-short acting β-blockers. Pharmazie 2003, 58:18-21.
- Stankovičová M, Bezáková Ž, Pavlíková J, Mažeriková J, Kissová M, Mokrý P, Csöllei J. Study of stability of potential beta-adrenolytics, derivatives of the [(arylcarbonyl)oxy]aminopropanol by kinetics of alkaline hydrolysis. Acta Facult Pharm Univ Comenianae. 2011, 58:72-80.
- Graham L, Patrick K. An Introduction to Medicinal Chemistry, Fourth Ed. Oxford University Press, 2009:620.
- Griffith RK. Adrenergics and adrenergic blocking agents. In ABRAHAM D. J.: Burger´s Medicinal Chemistry and Drug Discovery. Vol 6. Nervous System Agents. 6th ed. New York: John Willey & sons, 200:1-39.
- Watson DG. Pharmaceutical Chemistry. Churchil Livingstone Elsevier. 2011, p. 95.